Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial (Q58375672)
Jump to navigation
Jump to search
scientific article published on 27 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial |
scientific article published on 27 June 2012 |
Statements
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial (English)
Jeffrey I Weitz
Richard P Whitlock
Jack Hirsh
Kevin Teoh
Ed Young
Kyle A Arsenault
Jeremy S Paikin
Jeffrey S Ginsberg